Citric acid is not harmful to healthy kidneys and, in the form of citrate, is actually one of the body’s key defenses against kidney stones. Your kidneys naturally handle citrate every day as part of normal metabolism, and the evidence overwhelmingly points to citrate being protective rather than damaging. The picture gets more complicated for people who already have impaired kidney function, where specific drug interactions and electrolyte concerns come into play. And one widely circulated mouse study has muddied the waters in ways worth examining closely.
How Citrate Protects Against Kidney Stones
Citrate is one of the most important natural inhibitors of kidney stone formation. It works through two main mechanisms. First, citrate binds to calcium ions in urine, forming a soluble complex that keeps calcium from linking up with oxalate or phosphate to form the crystite crystals that become stones.1PubMed. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Second, citrate helps maintain urine pH near 6.0, a range that discourages stone-forming minerals from precipitating out of solution.2Seminars in Nephrology. Physiology of Acid-Base Balance: Links With Kidney Stone Prevention
This is why low urinary citrate, called hypocitraturia, is recognized as a major risk factor for calcium-based kidney stones. If your body is not excreting enough citrate in urine, calcium has more opportunity to crystallize. Genetics play a role here: hypocitraturia is a highly heritable trait, driven in part by a transporter protein in the kidney’s proximal tubule that reclaims citrate from urine before it can do its stone-preventing work.3Nephrology Dialysis Transplantation. Kidney stone biology: insights from genetics People who inherit a more active version of this transporter end up with less citrate in their urine and a higher stone risk, regardless of how much citric acid they consume.
When citrate is metabolized, it gets converted into bicarbonate, which alkalinizes the urine. That rise in urine pH, in turn, reduces the kidney’s reabsorption of citrate, creating a positive feedback loop: more citrate stays in the urine where it can bind calcium.4PubMed Central. Effect of citrus-based products on urine profile: A systematic review and meta-analysis This is the basic reason doctors prescribe potassium citrate to people who form recurrent kidney stones.
Lemon Juice Versus Potassium Citrate Supplements
If citrate prevents stones, the natural question is whether you can just drink lemon juice instead of taking a supplement. Lemons and other citrus fruits are among the richest dietary sources of citric acid, and there is genuine evidence they can help. One study found that about 85 milliliters of fresh lemon juice per day produced a 2.5-fold increase in urinary citrate levels in patients with low citrate and calcium stones.5PubMed. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study That same study found potassium citrate supplements produced a 3.5-fold increase, meaning the pharmaceutical version was more potent, but lemon juice still moved the needle substantially.
Not all studies agree on how effective lemon juice is, though. A head-to-head comparison found that potassium citrate significantly improved both citrate levels and urinary pH, while lemonade did not reach significance on either measure.6Urology. Comparison Between Lemonade and Potassium Citrate and Impact on Urine pH and 24-Hour Urine Parameters in Patients with Kidney Stone Formation The discrepancy likely comes down to dose and formulation. Freshly squeezed lemon juice delivers more concentrated citric acid than diluted lemonade, and the amount people actually consume day-to-day varies a lot. For someone with a documented stone problem, potassium citrate supplements remain the standard treatment. But for general prevention, regularly consuming citrus fruits and juices is a reasonable dietary strategy.
A pilot study in patients with gout and elevated uric acid found that daily lemon juice consumption over six weeks was associated with modest drops in serum creatinine and improvements in estimated kidney filtration rate among those who started with reduced function.7Annals of the Rheumatic Diseases. SAT0318 Lemon Juice Reduces Serum Uric Acid Level Via Alkalization of Urine in Gouty and Hyperuremic Patients- A Pilot Study That is a small, preliminary study, so the findings are suggestive rather than definitive. But they point in the same direction as the larger body of evidence: dietary citric acid tends to help kidney function, not hurt it.
The Mouse Study That Gets Cited as a Warning
If you have come across claims that citric acid damages kidneys, there is a good chance the source is a single 2014 study in mice. In that experiment, researchers gave mice citric acid at doses of 120, 240, and 480 milligrams per kilogram of body weight for seven days, then examined their kidney tissue. They found dose-dependent damage: shrunken glomeruli, swelling in the tubule cells, and markers of programmed cell death that increased with the dose.8PubMed. Effects of the food additive, citric acid, on kidney cells of mice
This study is real, but the context matters enormously. The doses used were high relative to what a human would typically consume from food or beverages. Mouse metabolism is also not a straightforward stand-in for human physiology; mice process substances at different rates and may respond to acute high doses in ways that do not predict chronic low-dose effects in people. The study used pure citric acid delivered directly, not citric acid arriving through food alongside other nutrients. And crucially, no comparable effect has been documented in human clinical trials or observational studies. Decades of clinical use of potassium citrate in stone-forming patients have not revealed a pattern of kidney tissue damage from citrate itself.
This does not mean the mouse study should be dismissed entirely. It highlights that extremely high concentrations of citric acid, delivered in isolation, can stress kidney cells. That is worth knowing for industrial safety or for researchers designing future studies. But it does not translate to a warning about drinking lemonade or eating foods that contain citric acid as an additive.
Manufactured Citric Acid and the Aspergillus Question
About 99% of the citric acid used as a food additive is not extracted from citrus fruits. It is produced industrially using the fungus Aspergillus niger, a process that has been standard since 1919.9PubMed Central. Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports Chemically, the citric acid molecule produced this way is identical to the one in a lemon. But a case report series raised the possibility that residual proteins or other traces from the fungal production process could trigger inflammatory reactions in sensitive individuals.
This is an important distinction to understand. The concern is not that manufactured citric acid is a different chemical. It is that the manufacturing process might leave behind trace contaminants from Aspergillus niger, which is a known allergen. The case reports described four patients with inflammatory symptoms that the authors attributed to manufactured citric acid exposure, though establishing causation from case reports alone is inherently limited. Regulatory agencies have generally maintained that food-grade manufactured citric acid is safe. Still, for anyone who notices inflammatory symptoms that seem linked to processed foods containing citric acid, it is a hypothesis worth discussing with a doctor.
From a kidney-specific standpoint, though, there is no evidence that manufactured citric acid behaves differently from natural citric acid in terms of kidney stone prevention, urinary citrate levels, or renal function. The molecule your kidneys encounter is the same either way.
Real Risks for People with Kidney Disease
Where citric acid genuinely becomes a concern is in people whose kidneys are already impaired. The risks are not from citric acid damaging the kidneys, but from how citric acid interacts with other aspects of kidney disease management.
The most well-documented danger involves aluminum. Patients with end-stage kidney disease have historically taken aluminum-containing phosphate binders to manage high phosphorus levels. When citric acid or citrate is consumed alongside these binders, it dramatically increases how much aluminum the gut absorbs. One study in hemodialysis patients found that the area under the curve for plasma aluminum was roughly four to five times higher when aluminum hydroxide was taken with sodium citrate/citric acid compared to aluminum hydroxide alone.10PubMed. Aluminum-citrate interaction in end-stage renal disease Aluminum is neurotoxic and accumulates when the kidneys cannot clear it, so this interaction is taken seriously. Patients on aluminum-based binders are generally warned to avoid citrate-containing products.
Potassium citrate supplements carry their own risk in kidney patients: hyperkalemia, or dangerously high blood potassium. Healthy kidneys efficiently excrete excess potassium, but compromised kidneys cannot keep up. A study of renal transplant patients found that potassium-bearing citrate supplements increased the risk of hyperkalemia, and the authors recommended close monitoring of blood potassium levels in that population.11PubMed Central. Safety of potassium-bearing citrate in patients with renal transplantation The problem here is the potassium, not the citrate. Sodium citrate or calcium citrate formulations avoid this issue, but any supplement use in someone with impaired kidney function should be supervised.
Citrate in Dialysis
Citrate has a separate medical role in dialysis, where it is used as a regional anticoagulant. When blood passes through the dialysis filter, it needs to be kept from clotting. Citrate achieves this by binding ionized calcium, which is essential for clotting. The approach is called regional citrate anticoagulation because the anticoagulant effect stays in the circuit rather than thinning the blood throughout the body.
The term “citrate toxicity” has been used in the dialysis literature to describe what happens when citrate accumulates in the blood faster than the body can metabolize it. The liver normally clears citrate rapidly, converting it to bicarbonate. But in patients with severe liver failure, this clearance stalls, and excess citrate binds too much calcium, causing dangerously low ionized calcium levels.12PubMed Central. Citrate anticoagulation for CRRT A study in children with liver failure receiving continuous dialysis found that about 70% experienced at least one episode of citrate accumulation, but this accumulation was not actually associated with increased adverse events compared to non-accumulation periods.13PubMed Central. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
Recent commentary has pushed back on the “citrate toxicity” label altogether. A 2024 review argued that citrate itself is not toxic; the problems attributed to it, specifically low ionized calcium and acid-base disturbances, are consequences of calcium binding and alkalosis from bicarbonate generation, not from any inherently harmful property of the citrate molecule.14PubMed. Let’s stop talking about ‘citrate toxicity’ The distinction matters because it reframes the issue from “citrate is dangerous” to “calcium and acid-base balance need careful management when citrate is used in high medical doses.”
Citrate and Polycystic Kidney Disease
One of the more intriguing areas of research involves citrate as a potential therapy for autosomal dominant polycystic kidney disease (ADPKD), a genetic condition in which fluid-filled cysts progressively enlarge the kidneys and destroy functional tissue. Animal studies have shown surprisingly strong results. In one experiment, rats with polycystic kidney disease that received potassium citrate starting at one month of age maintained normal kidney filtration rates at six months, while untreated rats had filtration rates about a third of normal. The treated rats lived an average of 17 months compared to 10 months for untreated animals.15Kidney International. Citrate therapy for polycystic kidney disease in rats
More recent work has confirmed and extended these findings. Citrate appears to prevent the formation of microcrystals that accelerate cyst growth, and when combined with beta-hydroxybutyrate (a ketone body), the effect on slowing disease progression was even stronger than either substance alone.16PubMed Central. A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease A 2025 review concluded that urinary citrate could serve both as a marker for disease progression and as a potential treatment, though it stressed that clinical trials in humans are still needed.17PubMed. Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?
These findings remain preclinical, so nobody should start treating their PKD with citrate supplements based on rat studies. But the direction of the evidence is striking: even in a disease that progressively destroys kidneys, citrate seems to slow the damage rather than add to it.
The Citric Acid Cycle and Chronic Kidney Disease
Citric acid is not just something you consume. It is a central molecule in the citric acid cycle, the metabolic pathway every cell uses to generate energy. Your kidneys are particularly energy-hungry organs, and research has found that disruptions to this cycle are a feature of chronic kidney disease (CKD). Blood and urine citrate levels tend to reflect how well the citric acid cycle is functioning, since there is no significant extra-renal elimination of citrate and oral intake has a minimal effect on blood levels.18EBioMedicine. Citric acid cycle and mitochondrial dysfunction in chronic kidney disease
In CKD, citrate excretion drops. Part of this is because mild acidosis, which is common in CKD, causes the kidney tubules to reabsorb more citrate. But the research suggests that even after accounting for acid-base changes, a significant portion of the decline in citrate excretion reflects genuine mitochondrial dysfunction in kidney cells. In other words, low urinary citrate in CKD patients is not just a stone risk factor; it may be a signal that the kidneys’ energy-producing machinery is faltering. This reframes citrate as a potential biomarker for kidney health rather than a threat to it.
Your Gut Bacteria May Influence Your Kidney’s Citrate Supply
An emerging line of research connects the gut microbiome to kidney stone formation through citrate. People who form calcium oxalate stones tend to have lower levels of certain beneficial gut bacteria, particularly species that produce short-chain fatty acids. A study comparing 59 stone formers with 60 healthy controls found that stone formers had significantly reduced microbial diversity, with depletion of species like Faecalibacterium prausnitzii and Eubacterium rectale. Their short-chain fatty acid levels in blood were lower, and so were their urinary citrate levels. Plasma short-chain fatty acid concentrations correlated positively with urinary citrate excretion, suggesting a regulatory link between gut health and urinary stone chemistry.19PubMed Central. Dysbiosis of the gut microbiota in calcium oxalate nephrolithiasis is associated with impaired short-chain fatty acid production and systemic metabolomic disruptions
A separate study exploring gut microbiome characteristics in patients with low-citrate stone disease reached similar conclusions, finding that microbial imbalance appeared to influence citrate metabolism through genetic and metabolic pathways.20PubMed. Exploring the characteristics of gut microbiome in patients of Southern Fujian with hypocitraturia urolithiasis and constructing clinical diagnostic models This research is still early, but it opens the possibility that gut health interventions, whether through diet, probiotics, or other approaches, could eventually become part of kidney stone prevention by boosting the body’s own citrate production. For now, it reinforces the idea that citrate is fundamentally protective in the urinary system, and that having too little of it is the problem, not too much.
Citrate in Pediatric Kidney Stone Treatment
Kidney stones in young children are less common than in adults but increasingly recognized, and metabolic disorders are frequently the underlying cause. In a study of 100 children under two years old with kidney stones or microlithiasis, the two most common metabolic abnormalities were excess uric acid and excess calcium in the urine, each present in roughly a third to 40% of patients. Treatment with potassium citrate produced complete resolution in 73 of the 100 patients, and the response did not differ significantly based on which metabolic disorder was present.21PubMed Central. Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders The fact that citrate therapy works across multiple types of metabolic stone disease in very young patients speaks to how broadly protective the mechanism is. It is not targeting one narrow pathway; it is raising the urine’s overall resistance to crystallization.
For parents who worry about citric acid in their child’s food or drink, this clinical use in pediatric nephrology offers useful context. Nephrologists are actively prescribing citrate to children with kidney problems, not warning families to avoid it. The therapeutic doses are higher and more controlled than what anyone would get from food, but the underlying principle is the same: citrate in the urinary tract prevents stone formation rather than promoting it.